US Stock MarketDetailed Quotes
GLMD Galmed Pharmaceuticals
- 3.2400
- 0.00000.00%
Close Nov 4 16:00 ET
- 3.1500
- -0.0900-2.78%
Post 17:30 ET
4.88MMarket Cap-310P/E (TTM)
3.5700High3.1500Low66.50KVolume3.1900Open3.2400Pre Close219.09KTurnover4.47%Turnover RatioLossP/E (Static)1.51MShares23.800052wk High0.41P/B4.82MFloat Cap2.730052wk Low--Dividend TTM1.49MShs Float4870.8000Historical High--Div YieldTTM12.96%Amplitude2.7300Historical Low3.2940Avg Price1Lot Size
Galmed Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 25.60%-1.02M | -7.96%-1.83M | 66.83%-6.14M | 77.68%-898K | 30.09%-2.18M | 76.87%-1.37M | 68.91%-1.7M | 43.75%-18.5M | 42.43%-4.02M | 65.34%-3.11M |
| Net income from continuing operations | 29.76%-1.12M | 30.33%-1.28M | 61.31%-6.91M | 23.61%-2.02M | 72.47%-1.47M | 57.34%-1.59M | 70.21%-1.83M | 44.97%-17.87M | 64.59%-2.64M | 30.65%-5.35M |
| Operating gains losses | 115.79%9K | -103.13%-1K | -97.51%13K | -105.75%-44K | 118.51%82K | -201.79%-57K | -77.93%32K | 1,513.51%523K | 15,400.00%765K | ---443K |
| Depreciation and amortization | 722.22%74K | 12.50%9K | -11.43%31K | -33.33%6K | 0.00%8K | 0.00%9K | -11.11%8K | -16.67%35K | -10.00%9K | -27.27%8K |
| Other non cash items | -108.23%-13K | 97.73%-4K | -30.56%-47K | 93.13%-32K | -99.36%3K | 593.75%158K | -1,660.00%-176K | -376.92%-36K | -7,866.67%-466K | 3,271.43%472K |
| Change In working capital | -145.54%-92K | -1,894.44%-718K | 105.39%132K | 154.68%993K | -152.24%-1.03M | 107.59%202K | -161.02%-36K | -0.04%-2.45M | -2,489.47%-1.82M | 206.50%1.97M |
| -Change in receivables | -47.58%119K | -12.06%226K | 15.00%345K | -11.04%290K | 20.11%-429K | -0.87%227K | -8.87%257K | 195.85%300K | -40.62%326K | 54.76%-537K |
| -Change in payables and accrued expense | -744.00%-211K | -222.18%-944K | 92.26%-213K | 132.82%703K | -123.89%-598K | 99.13%-25K | -31.39%-293K | -28.73%-2.75M | -352.85%-2.14M | 479.82%2.5M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 25.60%-1.02M | -7.96%-1.83M | 66.83%-6.14M | 77.68%-898K | 30.09%-2.18M | 76.87%-1.37M | 68.91%-1.7M | 43.75%-18.5M | 42.43%-4.02M | 65.34%-3.11M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 97.45%1.39M | -68.02%432K | -95.44%800K | 15.16%2.28M | -168.98%-3.54M | -83.01%705K | -78.59%1.35M | 53.23%17.56M | -69.01%1.98M | 12.59%5.13M |
| Net PPE purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 63.64%-4K | 0.00%-1K | --0 |
| Net business purchase and sale | ---- | ---- | ---1.5M | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
| Net investment purchase and sale | -36.87%1.39M | -68.02%432K | -86.91%2.3M | 15.10%2.28M | -168.98%-3.54M | -46.91%2.21M | -78.59%1.35M | 53.10%17.57M | 134.85%1.98M | -69.17%5.13M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 97.45%1.39M | -68.02%432K | -95.44%800K | 15.16%2.28M | -168.98%-3.54M | -83.01%705K | -78.59%1.35M | 53.23%17.56M | -69.01%1.98M | 12.59%5.13M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 8,735.71%6.19M | 0 | -99.60%70K | 0 | ||||||
| Net common stock issuance | ---- | ---- | 8,735.71%6.19M | --0 | ---- | ---- | ---- | -99.60%70K | --0 | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | 8,735.71%6.19M | --0 | ---- | ---- | ---- | -99.60%70K | --0 | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -11.53%1.58M | 39.81%2.98M | -28.95%2.13M | -61.75%1.6M | -46.32%1.12M | -53.67%1.79M | -28.95%2.13M | -57.54%3M | 15.88%4.18M | -73.94%2.09M |
| Current changes in cash | 156.65%375K | -306.40%-1.4M | 197.70%848K | 167.53%1.38M | -77.27%473K | 62.41%-662K | -140.14%-344K | 78.63%-868K | -238.02%-2.05M | 146.94%2.08M |
| End cash Position | 73.93%1.96M | -11.53%1.58M | 39.81%2.98M | 39.81%2.98M | -61.75%1.6M | -46.32%1.12M | -53.67%1.79M | -28.95%2.13M | -28.95%2.13M | 15.88%4.18M |
| Free cash flow | 25.60%-1.02M | -7.96%-1.83M | 66.84%-6.14M | 77.69%-898K | 30.09%-2.18M | 76.89%-1.37M | 68.91%-1.7M | 43.76%-18.51M | 42.43%-4.03M | 65.35%-3.11M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data